Russia announced the development of an mRNA cancer vaccine
which is expected to be released in 2025. Preclinical studies show a decrease in metastases and tumor defeat. AI integration has the potential to greatly speed up the existing drawn-out process by personalizing vaccine creation in as little as one hour. The goal of the vaccine is to increase the immune system’s capacity to recognize and destroy cancer cells Personalizing
In what can be said to be the discovery of the century, the Russian government says it has developed its cancer vaccine. The vaccine is expected to be launched in early 2025. “Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health Andrey Kaprin has told Radio Rossiya
Vaccines can be created by AI in one hour.
Amidst vaccine trials, Gintsburg told the media that the use of artificial neural networks could bring down the duration of computing required to create a personalized cancer vaccine, which is currently a lengthy process, to less than an hour. “Now it takes quite a long to build [personalized vaccines] because computing how a vaccine, or customized mRNA, should look like uses matrix methods, in mathematical terms. We have involved the Ivannikov Institute which will rely on AI in doing this math, namely neural network computing where these procedures should take about half an hour to an hour,” Russia’s vaccine chief said.
Vaccines’ function in the treatment of cancer
By encouraging the immune system to identify and target cancer cells, vaccines can fight cancer. Therapeutic cancer vaccines teach the immune system to recognise and eliminate tumour cells by targeting particular proteins or antigens that are expressed by these cells. To elicit a robust immune response, certain vaccines, for example, employ viruses that have been weakened or altered to deliver these antigens. By protecting against viruses associated to cancer, preventive immunisations like the HPV vaccine lower the chance of developing some types of cancer, including cervical cancer. Vaccines are a promising therapy in oncology because they can delay tumour growth, prevent recurrence, or even eradicate early-stage tumours by strengthening the body’s natural defences.
which is expected to be released in 2025. Preclinical studies show a decrease in metastases and tumor defeat. AI integration has the potential to greatly speed up the existing drawn-out process by personalizing vaccine creation in as little as one hour. The goal of the vaccine is to increase the immune system’s capacity to recognize and destroy cancer cells Personalizing
In what can be said to be the discovery of the century, the Russian government says it has developed its cancer vaccine. The vaccine is expected to be launched in early 2025. “Russia has developed its own mRNA vaccine against cancer, it will be distributed to patients free of charge, General Director of the Radiology Medical Research Center of the Russian Ministry of Health Andrey Kaprin has told Radio Rossiya
Vaccines can be created by AI in one hour.
Amidst vaccine trials, Gintsburg told the media that the use of artificial neural networks could bring down the duration of computing required to create a personalized cancer vaccine, which is currently a lengthy process, to less than an hour. “Now it takes quite a long to build [personalized vaccines] because computing how a vaccine, or customized mRNA, should look like uses matrix methods, in mathematical terms. We have involved the Ivannikov Institute which will rely on AI in doing this math, namely neural network computing where these procedures should take about half an hour to an hour,” Russia’s vaccine chief said.
Vaccines’ function in the treatment of cancer
By encouraging the immune system to identify and target cancer cells, vaccines can fight cancer. Therapeutic cancer vaccines teach the immune system to recognise and eliminate tumour cells by targeting particular proteins or antigens that are expressed by these cells. To elicit a robust immune response, certain vaccines, for example, employ viruses that have been weakened or altered to deliver these antigens. By protecting against viruses associated to cancer, preventive immunisations like the HPV vaccine lower the chance of developing some types of cancer, including cervical cancer. Vaccines are a promising therapy in oncology because they can delay tumour growth, prevent recurrence, or even eradicate early-stage tumours by strengthening the body’s natural defences.
